FEATURE SESSION: Hosted by CPI
Revolutionising Medicines Manufacturing Takes Serious Collaboration Feature session - Hosted by CPI
Time & Location
Wednesday: 11.00 to 12.00, Stage 3
Hosted by CPI
Dr. Neil SheddanBusiness Development Director, Medicines Manufacturing Innovation Centre at CPI
About this Session
FEATURE SESSION & PANEL: Hosted by CPI
Revolutionising Medicines Manufacturing Takes Serious Collaboration Feature session
If partnering has crossed your mind when looking at ways to accelerate your innovation but don’t know where to start, come along to learn how CPI is leveraging the power of partnerships to overcome some of the challenges
to successful collaboration. Through a Grand Challenge model, aimed at tackling the pharmaceutical industry’s largest problems, CPI’s Medicines
Manufacturing Innovation Centre is working together with collaborators in a pre-competitive environment, to break down barriers previously limiting the ability and speed of new and innovative technology adoption.
Session coordinator: Dr. Neil Sheddan, Business Development Director, Medicines Manufacturing Innovation Centre at CPI
Speakers /Panellists include:
CPI Pharma Capability Overview:
- Dr. Sam Neill, Business Development Director – CPI
- Dr. Caroline Kelly, Head of Technology Strategy – CPI
Medicines Manufacturing Innovation Centre: Grand Challenge Overview
- Dr. Barrie Cassey, Grand Challenge Lead – CPI
- Dr. Dave Berry, Grand Challenge and Digital Strategy Lead – CPI
Panel discussion hosted by Katie Murray, Technology Director, CPI
- Dr. Barrie Cassey, Grand Challenge Lead, CPI
- Dr. Marcus Cook, Head of Engineering, Exactmer
- Terry Reed, Director Business Development, Astra Zeneca
Neil is a seasoned business development professional with over 20 years’ experience from academia and the pharmaceutical & chemical industries working across Europe in Denmark, Germany, Austria, and the UK. Prior to joining CPI, he has held senior leadership roles in commercial, technical, and R&D teams at academic institutions, SME and multinational organisations including the University of Vienna, Loba Feinchemie and most recently Johnson Matthey.
Neil joined CPI in 2019 and as Business Development Director is responsible for identifying, developing, and delivering new business partnerships and opportunities aligned with the Medicines Manufacturing Innovation Centre’s technology strategy. Neil holds a Doctorate in Organic Chemistry from the University of Vienna, is a Chartered Chemist, a member of the Royal Society of Chemistry and active STEM ambassador.
He has a genuine passion for scientific innovation, cultivating meaningful partnerships and making strategic connections across industry and academia to promote collaboration and drive greater societal benefits.